Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Apr 05, 2024

SELL
$34.54 - $47.25 $117,436 - $160,650
-3,400 Closed
0 $0
Q4 2019

Apr 05, 2024

BUY
$53.85 - $65.27 $183,090 - $221,918
3,400 New
3,400 $205 Million
Q3 2016

Apr 05, 2024

SELL
N/A
-2,800 Closed
0 $0
Q4 2015

Apr 05, 2024

BUY
N/A
2,800
2,800 $173 Million

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.35B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track E. Ohman J:Or Asset Management Ab Portfolio

Follow E. Ohman J:Or Asset Management Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of E. Ohman J:Or Asset Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on E. Ohman J:Or Asset Management Ab with notifications on news.